News

Tamoxifen reduces breast cancer by a third in high risk women

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.613/a (Published 21 September 2002) Cite this as: BMJ 2002;325:613
  1. Susan Mayor
  1. London

    Tamoxifen reduces the risk of breast cancer by a third over four years in healthy women at high risk of developing the disease, a major international study has shown.

    But the investigators consider that the increased risk of thromboembolism and endometrial cancers from the drug means that longer term follow up is needed before a clear recommendation can be made on its use in primary breast cancer prevention.

    Results …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe